Danaher Co. (DHR) Given Consensus Rating of “Buy” by Analysts

Shares of Danaher Co. (NYSE:DHR) have been assigned an average recommendation of “Buy” from the twenty-two ratings firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and seventeen have given a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $105.44.

DHR has been the topic of several recent research reports. Robert W. Baird reiterated a “buy” rating on shares of Danaher in a research report on Friday, January 12th. Barclays initiated coverage on shares of Danaher in a research report on Thursday, February 15th. They issued an “overweight” rating and a $110.00 price objective on the stock. Royal Bank of Canada reiterated a “hold” rating and issued a $96.00 price objective on shares of Danaher in a research report on Thursday, January 4th. Stifel Nicolaus lifted their price objective on shares of Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Wednesday, January 31st. Finally, ValuEngine upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd.

How to Become a New Pot Stock Millionaire

Shares of NYSE DHR traded down $0.16 during midday trading on Friday, hitting $101.34. The company’s stock had a trading volume of 3,660,098 shares, compared to its average volume of 2,058,742. Danaher has a 1-year low of $78.97 and a 1-year high of $104.82. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43. The firm has a market capitalization of $70,691.64, a PE ratio of 25.15, a price-to-earnings-growth ratio of 1.91 and a beta of 1.03.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, April 19th. The conglomerate reported $0.99 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.94 by $0.05. Danaher had a net margin of 13.56% and a return on equity of 11.59%. The business had revenue of $4.70 billion during the quarter, compared to analyst estimates of $4.54 billion. During the same period in the previous year, the business posted $0.85 EPS. The company’s quarterly revenue was up 11.6% on a year-over-year basis. equities analysts forecast that Danaher will post 4.45 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, March 29th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.63%. This is an increase from Danaher’s previous quarterly dividend of $0.14. The ex-dividend date is Wednesday, March 28th. Danaher’s payout ratio is 15.88%.

In other Danaher news, EVP William K. Daniel sold 131,066 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the sale, the executive vice president now directly owns 270,523 shares in the company, valued at approximately $27,606,872.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Walter G. Lohr sold 10,578 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $97.90, for a total transaction of $1,035,586.20. Following the sale, the director now owns 19,821 shares in the company, valued at $1,940,475.90. The disclosure for this sale can be found here. Insiders have sold a total of 313,260 shares of company stock worth $31,657,786 over the last 90 days. 11.90% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Zions Bancorporation raised its holdings in shares of Danaher by 118.3% in the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after purchasing an additional 667 shares in the last quarter. First Personal Financial Services increased its position in shares of Danaher by 128.9% in the fourth quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after acquiring an additional 691 shares in the last quarter. Calton & Associates Inc. purchased a new position in shares of Danaher in the fourth quarter worth approximately $114,000. CNB Bank purchased a new position in shares of Danaher in the fourth quarter worth approximately $116,000. Finally, Truewealth LLC purchased a new position in shares of Danaher in the fourth quarter worth approximately $121,000. Institutional investors and hedge funds own 77.65% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Danaher Co. (DHR) Given Consensus Rating of “Buy” by Analysts” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright legislation. The original version of this article can be viewed at https://ledgergazette.com/2018/04/22/danaher-co-dhr-given-consensus-rating-of-buy-by-analysts.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply